EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Landscape of Pediatric Low‐Grade Gliomas: Insights From RNA ‐ NGS and Bioinformatic Analysis

Petr Brož iD, Martina Strnadová iD, Denisa Olejníková iD, Johana Kotiš iD, Tereza Pospíšilíková iD, Adéla Mišove iD, Miroslav Koblížek iD, Josef Zámečník iD, Michal Zápotocký iD, David Sumerauer iD, Aleš Vícha iD, Martin Kynčl iD und 3 weitere

Genes, Chromosomes and Cancer · 2025

DOI: 10.1002/gcc.70085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, Chromosomes and Cancer, 2025. Verfasst von Petr Brož und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MH CZ-DRO, University Hospital Motol, Prague, Czech Republic, The foundation "Nation to Children", the project "1000 Braves", The project National Institute for Cancer Research (Program EXCELES, Funded by the European Union-Next Generation EU).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pediatric low‐grade gliomas (pLGG) are the most common group of childhood brain tumors. Genetic alterations in the RAS–RAF–mitogen‐activated protein kinase (MAPK) pathway are the molecular drivers in the vast majority of pLGG. A large proportion of pediatric pLGG are characterized by the presence of fusion genes. An institutional molecular analysis together with an RNA‐NGS study was performed to reveal LGG‐associated molecular alterations. In our cohort of pLGG patients, molecular alterations were identified in 318 out of 342 cases (92.9%) through a combination of RT‐PCR, Sanger sequencing, and NGS methodologies. Fusion events were independently called using three fusion callers: Archer Analysis 6.0 and/or 7.0, Arriba version 2.4, and STAR‐Fusion 24. Among these, STAR‐Fusion had the lowest sensitivity, detecting rearrangements in only 67% of fusion‐positive cases. In contrast, Arriba detected rearrangements in 97.77% of cases, while Archer detected rearrangements in 88.6% of cases. These findings highlight differences in detection efficiency among fusion callers, emphasizing the importance of tool selection in molecular diagnostics. The detection of fusion genes is very important for correct diagnosis, prognosis, and adequate targeted treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBrain NeoplasmsHumansChildMaleFemaleComputational BiologyChild, PreschoolAdolescentHigh-Throughput Nucleotide SequencingOncogene Proteins, FusionInfantNeoplasm GradingSequence Analysis, RNA

Stichwörter der Autor:innen

RNA NGSbioinformatics analysisfusion geneslow‐grade glioma

Substanzen

Oncogene Proteins, Fusion

Autor:innen und Institutionen

  • Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
  • Bioxsys Ltd, Ústí nad Labem, Czech Republic.
  • Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
  • Department of Radiology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
  • Department of Neurosurgery, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
  • Department of Genetics and Molecular Diagnostics, Regional Hospital Liberec, Liberec, Czech Republic.

ORCID-Profile: Petr Brož, Martina Strnadová, Denisa Olejníková, Johana Kotiš, Tereza Pospíšilíková, Adéla Mišove, Miroslav Koblížek, Josef Zámečník, Michal Zápotocký, David Sumerauer, Aleš Vícha, Martin Kynčl, Petr Libý, Vladimír Beneš, Lenka Krsková

Förderung

  • MH CZ-DRO, University Hospital Motol, Prague, Czech Republic
  • The foundation "Nation to Children", the project "1000 Braves"
  • The project National Institute for Cancer Research (Program EXCELES, Funded by the European Union-Next Generation EU)

Zitieren

APA

Brož, P., Strnadová, M., Olejníková, D., Kotiš, J., Pospíšilíková, T., Mišove, A., Koblížek, M., Zámečník, J., Zápotocký, M., Sumerauer, D., Vícha, A., Kynčl, M., Libý, P., Beneš, V., & Krsková, L. (2025). Molecular Landscape of Pediatric Low‐Grade Gliomas: Insights From RNA ‐ NGS and Bioinformatic Analysis. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.70085

Vancouver

Brož P, Strnadová M, Olejníková D, Kotiš J, Pospíšilíková T, Mišove A, et al. Molecular Landscape of Pediatric Low‐Grade Gliomas: Insights From RNA ‐ NGS and Bioinformatic Analysis. Genes, Chromosomes and Cancer. 2025. doi:10.1002/gcc.70085

BibTeX
@article{Bro2025,
  author = {Brož, Petr and Strnadová, Martina and Olejníková, Denisa and Kotiš, Johana and Pospíšilíková, Tereza and Mišove, Adéla and Koblížek, Miroslav and Zámečník, Josef and Zápotocký, Michal and Sumerauer, David and Vícha, Aleš and Kynčl, Martin and Libý, Petr and Beneš, Vladimír and Krsková, Lenka},
  title = {Molecular Landscape of Pediatric Low‐Grade Gliomas: Insights From RNA ‐ NGS and Bioinformatic Analysis},
  journal = {Genes, Chromosomes and Cancer},
  year = {2025},
  doi = {10.1002/gcc.70085}
}
Kostenlos starten →